High triglyceride recommended long-term medication, hyperlipidemia including hypertriglyceridemia and hypercholesterolemia, for patients with predominantly increased triglyceride, can take the lipid-lowering drugs of the beta class, such as fenofibrate. It is recommended that liver function tests be carried out for about 1 month during the medication period, because lipid-lowering drugs will be metabolized by the liver, and in the process of metabolism will play a role in the elevation of indicators such as glutamic oxaloacetic aminotransferase, glutamic alanine aminotransferase, and the enzyme alkaline phosphatase, etc. If there is a significant increase in the above indicators when liver function monitoring is carried out, it is recommended that the drug be discontinued or the drug be reduced in dosage. Patients with high triglycerides should take oral lipid-lowering drugs for a long time, but need to monitor liver function and other indicators.